ArticleHeliyon2025
Green nanoparticles synthesized from damask rose petals: Evaluation of their antioxidant, antimicrobial, anti-diabetic, anti-Alzheimer, and photocatalytic properties.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synthesis and Characterization of Mg-Doped CuO Nanoparticles and Their Enhanced Anticancer Efficacy Against HepG2 Liver Cancer Cells.International journal of molecular sciences · 2026Article
- Sustainable nanomaterials for precision dental medicine: green synthesis, therapeutic applications, and future directions.Journal of nanobiotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green synthesis, an approach that has gained widespread recognition in recent years due to environmental and health concerns, was employed to synthesize green zinc oxide nanoparticles (G-ZnO NPs) using a hydro-alcoholic extract derived from dried damask rose petals. The synthesized nanoparticles were confirmed using an X-ray diffractometer, UV-visible, and Fourier transform infrared spectrometry. A morphological examination with a field emission scanning electron microscope revealed that the G-ZnO NPs had a diameter ranging from 44.66 to 83.74 nm and a purity of 93.2 %. Furthermore, the antioxidant, photocatalytic, antimicrobial, and anti-diabetic properties of G-ZnO NPs were investigated and compared with two commercial ZnO NPs of different sizes (C-ZnO NPs1 (10-30 nm) and C-ZnO NPs2 (50-60 nm)). The G-ZnO NPs demonstrated the highest antioxidant activity (46.49 %). In terms of photocatalytic activity against methylene blue, G-ZnO NPs exhibited a higher degradation rate (61 %) than C-ZnO NPs1 and C-ZnO NPs2 (53.65 and 25.63 %). The ability of nanoparticles to inhibit the growth of two bacteria
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.